Distribution of Neuropeptide S Receptor Mrna and Neurochemical Characteristics of Neuropeptide S- Expressing Neurons in the Rat Brain

Total Page:16

File Type:pdf, Size:1020Kb

Distribution of Neuropeptide S Receptor Mrna and Neurochemical Characteristics of Neuropeptide S- Expressing Neurons in the Rat Brain THE JOURNAL OF COMPARATIVE NEUROLOGY 500:84–102 (2007) Distribution of Neuropeptide S Receptor mRNA and Neurochemical Characteristics of Neuropeptide S- Expressing Neurons in the Rat Brain YAN-LING XU,1 CHRISTINE M. GALL,2 VALERIE R. JACKSON,1,3 OLIVIER CIVELLI,1,3 AND RAINER K. REINSCHEID1,4* 1Department of Pharmacology, University of California Irvine, Irvine, California 92697 2Department of Anatomy and Neurobiology, University of California Irvine, Irvine, California 92697 3Department of Developmental and Cell Biology, University of California Irvine, Irvine, California 92697 4Program in Pharmaceutical Sciences, University of California Irvine, Irvine, California 92697 ABSTRACT Neuropeptide S (NPS) and its receptor (NPSR) constitute a novel neuropeptide system that is involved in regulating arousal and anxiety. The NPS precursor mRNA is highly expressed in a previously undescribed group of neurons located between the locus coeruleus (LC) and Bar- rington’s nucleus. We report here that the majority of NPS-expressing neurons in the LC area and the principal sensory trigeminal nucleus are glutamatergic neurons, whereas many NPS- positive neurons in the lateral parabrachial nucleus coexpress corticotropin-releasing factor (CRF). In addition, we describe a comprehensive map of NPSR mRNA expression in the rat brain. High levels of expression are found in areas involved in olfactory processing, including the anterior olfactory nucleus, the endopiriform nucleus, and the piriform cortex. NPSR mRNA is expressed in several regions mediating anxiety responses, including the amygdaloid complex and the paraventricular hypothalamic nucleus. NPSR mRNA is also found in multiple key regions of sleep neurocircuitries, such as the thalamus, the hypothalamus, and the preoptic region. In addition, NPSR mRNA is strongly expressed in major output and input regions of hippocampus, including the parahippocampal regions, the lateral entorhinal cortex, and the retrosplenial agranular cortex. Multiple hypothalamic nuclei, including the dorsomedial and the ventromedial hypothalamic nucleus and the posterior arcuate nucleus, express high levels of NPSR mRNA, indicating that NPS may regulate energy homeostasis. These data suggest that the NPS system may play a key role in modulating a variety of physiological functions, especially arousal, anxiety, learning and memory, and energy balance. J. Comp. Neurol. 500:84–102, 2007. © 2006 Wiley-Liss, Inc. Indexing terms: G protein-coupled receptor; in situ hybridization; expression pattern; locus coeruleus; glutamate; corticotropin-releasing factor; acetylcholine; GABA Neuropeptide S (NPS) and its receptor (NPSR) form a newly discovered neuropeptide system. In the rat, NPS is encoded by a precursor protein of 89 amino acids, contain- ing a typical amino-terminal signal peptide. The imma- Grant sponsor: National Institutes of Health; Grant number: MH-71313 ture NPS peptide sequence is preceded by a pair of basic (to R.K.R.); Grant number: MH-60231 (to O.C.); Grant number: DK-63001 amino acids (Lys-Arg) that are presumably cleaved by (to O.C.); Grant number: DK-70619 (to O.C.); Grant sponsor: National prohormone convertases to release the 20-amino-acid-long Alliance for Research on Schizophrenia and Depression (to R.K.R.). peptide (primary structure of rNPS: SFRNGVGS- *Correspondence to: Rainer K. Reinscheid, Program in Pharmaceutical Sciences, University of California Irvine, 360 Med Surge II, Irvine, CA GVKKTSFRRAKQ). Pharmacologically, NPS activates 92697-4625. E-mail: [email protected] NPSR at low nanomolar concentration, induces mobiliza- Received 7 April 2006; Revised 16 June 2006; Accepted 31 July 2006 2ϩ tion of intracellular Ca , increases intracellular levels of DOI 10.1002/cne.21159 cAMP, and stimulates phosphorylation of mitogen- Published online in Wiley InterScience (www.interscience.wiley.com). © 2006 WILEY-LISS, INC. The Journal of Comparative Neurology. DOI 10.1002/cne ANATOMICAL CHARACTERIZATION OF RAT NPS SYSTEM 85 activated protein kinase (Xu et al., 2004b; Reinscheid et in the pontine brainstem (Xu et al., 2004b). Thus, the al., 2005). Physiologically, central administration of NPS identity of any classical neurotransmitters in this novel in rodents induces hyperlocomotion, increases arousal and group of neurons in the LC area is still unknown. It is well wakefulness, and suppresses all stages of sleep. NPS ad- established that neuropeptides usually do not exist alone ministration also reduces anxiety-like behaviors in a bat- as neurotransmitters but colocalize with classical neuro- tery of four different tests that measure innate fear or transmitters or with other neuropeptides and may play responses to novelty in rodents (Xu et al., 2004b). Anatom- important roles in modulating the activities of these ically, we have shown that NPS precursor mRNA is ex- neurotransmitters/neuromodulators (Hokfelt et al., 2000). pressed only in several discrete regions in the rat brain. It has been reported that ␥-aminobutyric acid (GABA)- The dorsomedial hypothalamus and amygdala contain ergic neurons (Aston-Jones et al., 2004), cholinergic neu- scattered NPS precursor mRNA signals. Strong expres- rons (Sutin and Jacobowitz, 1988; Rizvi et al., 1994), and sion of NPS precursor mRNA was observed in three brain- glutamatergic neurons (Stornetta et al., 2002; Varoqui et stem regions, including the principle sensory trigeminal al., 2002; Moriyama and Yamamoto, 2004) are present in nucleus, lateral parabrachial nucleus, and locus coeruleus LC and the surrounding peri-LC area. In this study, we (LC) area. The NPS-expressing neurons in the LC area are therefore determined the chemical neuroanatomy of NPS- localized ventromedial to the LC and caudolateral to Bar- expressing cells in the rat brainstem, by using glutamate rington’s nucleus, a neighboring nucleus of LC that is acid decarboxylase 67 (GAD67; Lauterborn et al., 1995), often referred to as the pontine micturition center. The choline acetyltransferase (ChAT; Lauterborn et al., 1993), unique anatomical pattern of this group of NPS- and vesicular glutamate transporters (VGLUTs; Smith et expressing neurons reveals a previously unmapped popu- al., 2001; McCullumsmith and Meador-Woodruff, 2003) as lation of cells between Barrington’s nucleus and the LC. In markers for GABAergic, cholinergic, and glutamatergic our previous study, we have demonstrated that neither neurons, respectively. This study will reveal for the first noradrenaline (NA), the major neurotransmitter synthe- time the neurochemical profiles of NPS-producing neu- sized in LC neurons, nor corticotropin-releasing factor rons and the neurotransmitters/neuromodulators that (CRF), the major peptidergic transmitter in Barrington’s may be coreleased with NPS peptide. Identification of nucleus, is expressed in the NPS-synthesizing cell cluster coexisting transmitters in NPS-producing neurons will Abbreviations 3V third ventricle MPT medial pretectal nucleus 4V fourth ventricle OPT olivary pretectal nucleus ac anterior commissure opt optical tract aca anterior commissure, anterior part ox optic chiasm ACo anterior cortical amygdaloid nucleus PAG periaqueductal gray AH anterior hypothalamic area PaMP medial parvicellular paraventricular hypothalamic nu- AMV anteromedial thalamic nucleus, ventral part cleus AON anterior olfactory nucleus PaPo paraventricular hypothalamic nucleus, posterior part Apir amygdalopiriform transition area PaS parasubiculum aq aqueduct PaV paraventricular hypothalamic nucleus, ventral part Arc P arcuate hypothalamic nucleus, posterior part pc posterior commissure CA1 CA1 region of the hippocampus PeF perifornical nucleus Cb cerebellum PH posterior hypothalamic nucleus cc corpus callosum Pir piriform cortex Cg1 cingulate cortex, area 1 PLi posterior limitans thalamic nucleus Cl claustrum PMCo posteromedial cortical amygdala CLi caudal linear nucleus of raphe PMD premammillary nucleus, dorsal part CM central medial thalamic nucleus PMV premammillary nucleus, ventral part cp cerebral peduncle Post postsubiculum DEn dorsal endopiriform nucleus Pr5 principle sensory 5 nucleus DG dentate gyrus PrC precommissural nucleus DMH dorsomedial hypothalamic nucleus PrS presubiculum DpG deep gray layer of superior colliculus PT paratenial thalamic nucleus DR dorsal raphe DTM dorsal tuberomammillary nucleus PtA parietal association cortex En endopiriform nucleus PVP paraventricular thalamic nucleus, posterior f fornix Re reuniens thalamic nucleus HDB nucleus of the horizontal limb of the diagonal band Rh rhomboid thalamic nucleus Hpx hippocampus RSA retrosplenial agranular cortex I intercalated nuclei of amygdala S subiculum IAM interanteromedial thalamic nucleus SCO subcommissural organ IPR interpeduncular nucleus, rostral part scp superior cerebellar peduncle LC locus coeruleus SG suprageniculate thalamic nucleus LENt lateral entorhinal cortex SNCD substantia nigra, compact part, dorsal tier LH lateral hypothalamic area SuG superficial layer of superior colliculus LPB lateral parabrachial nucleus Tg/PnO tegmental area/pontine reticular nucleus, oral part LPO lateral preoptic area VLPO ventrolateral preoptic nucleus LV lateral ventricle VMH ventromedial hypothalamic nucleus M2 motor cortex 2 VMHDM ventromedial hypothalamic nucleus, dorsomedial part MeAD medial amygdala, anterodorsal part VTA ventral tegmental area MePD/V medial amygdala, posterodorsal/ventral VTM ventral tuberomammillary nucleus MnR median raphe nucleus Xi xiphoid thalamic nucleus The Journal of Comparative Neurology. DOI 10.1002/cne
Recommended publications
  • Hypothalamic Mechanisms Associated with Corticotropin-Releasing Factor- Induced Anorexia in Chicks T ⁎ Jinxin Wanga, Justin Matiasa, Elizabeth R
    Neuropeptides 74 (2019) 95–102 Contents lists available at ScienceDirect Neuropeptides journal homepage: www.elsevier.com/locate/npep Hypothalamic mechanisms associated with corticotropin-releasing factor- induced anorexia in chicks T ⁎ Jinxin Wanga, Justin Matiasa, Elizabeth R. Gilberta,b, Tetsuya Tachibanac, Mark A. Clinea,b, a Department of Animal and Poultry Sciences, School of Neuroscience, USA b Virginia Polytechnic Institute and State University, Blacksburg 24061, VA, USA c Department of Agrobiological Science, Faculty of Agriculture, Ehime University, Matsuyama 790-8566, Japan ARTICLE INFO ABSTRACT Keywords: Central administration of corticotropin-releasing factor (CRF), a 41-amino acid peptide, is associated with potent Arcuate nucleus anorexigenic effects in rodents and chickens. However, the mechanism underlying this effect remains unclear. Chick Hence, the objective of the current study was to elucidate the hypothalamic mechanisms that mediate CRF- Corticotropin-releasing factor induced anorexia in 4 day-old Cobb-500 chicks. After intracerebroventricular (ICV) injection of 0.02 nmol of Hypothalamus CRF, CRF-injected chicks ate less than vehicle chicks while no effect on water intake was observed at 30 min Paraventricular nucleus post-injection. In subsequent experiments, the hypothalamus samples were processed at 60 min post-injection. The CRF-injected chicks had more c-Fos immunoreactive cells in the arcuate nucleus (ARC), dorsomedial nucleus (DMN), ventromedial hypothalamus (VMH), and paraventricular nucleus (PVN) of the hypothalamus than ve- hicle-treated chicks. CRF injection was associated with decreased whole hypothalamic mRNA abundance of neuropeptide Y receptor sub-type 1 (NPYR1). In the ARC, CRF-injected chicks expressed more CRF and CRF receptor sub-type 2 (CRFR2) mRNA but less agouti-related peptide (AgRP), NPY, and NPYR1 mRNA than ve- hicle-injected chicks.
    [Show full text]
  • Mutant Neuropeptide S Receptor Reduces Sleep Duration with Preserved Memory Consolidation Lijuan Xing, Guangsen Shi, Yulia Mostovoy, Nicholas W
    SCIENCE TRANSLATIONAL MEDICINE | RESEARCH ARTICLE SLEEP Copyright © 2019 The Authors, some rights reserved; Mutant neuropeptide S receptor reduces sleep duration exclusive licensee American Association with preserved memory consolidation for the Advancement Lijuan Xing1*, Guangsen Shi1*, Yulia Mostovoy2, Nicholas W. Gentry1, Zenghua Fan1, of Science. No claim 1 2,3,4 5 1,4,6,7† 1,4,6,7† to original U.S. Thomas B. Mcmahon , Pui-Yan Kwok , Christopher R. Jones , Louis J. Ptáček , Ying-Hui Fu Government Works Sleep is a crucial physiological process for our survival and cognitive performance, yet the factors controlling hu- man sleep regulation remain poorly understood. Here, we identified a missense mutation in a G protein–coupled neuropeptide S receptor 1 (NPSR1) that is associated with a natural short sleep phenotype in humans. Mice carry- ing the homologous mutation exhibited less sleep time despite increased sleep pressure. These animals were also resistant to contextual memory deficits associated with sleep deprivation. In vivo, the mutant receptors showed Downloaded from increased sensitivity to neuropeptide S exogenous activation. These results suggest that the NPS/NPSR1 pathway might play a critical role in regulating human sleep duration and in the link between sleep homeostasis and mem- ory consolidation. INTRODUCTION In this study, we identified another FNSS family and report a http://stm.sciencemag.org/ Sleep remains a relatively understudied phenomenon, despite being mutation in the NPSR1 gene causing a short sleep phenotype. Neu- essential in some form to most vertebrate life. Although humans ropeptide S receptor 1 (NPSR1) is a G protein–coupled receptor spend about one-third of their lives in the sleep state, an under- whose cognate ligand, neuropeptide S (NPS), has been reported to standing and recognition of its importance for our well-being are modulate arousal and sleep behaviors (17).
    [Show full text]
  • Discovery of an Ancient Role As Muscle Relaxants
    Original citation: Cai, Weigang, Kim, Chan-Hee, Go, Hye-Jin, Egertová, Michaela, Zampronio, Cleidiane, Jones, Alexandra M., Park, Nam Gyu and Elphick, Maurice R. (2018) Biochemical, anatomical, and pharmacological characterization of calcitonin-type neuropeptides in starfish : discovery of an ancient role as muscle relaxants. Frontiers in Neuroscience, 12 . 382. doi:10.3389/fnins.2018.00382 Permanent WRAP URL: http://wrap.warwick.ac.uk/103092 Copyright and reuse: The Warwick Research Archive Portal (WRAP) makes this work of researchers of the University of Warwick available open access under the following conditions. This article is made available under the Creative Commons Attribution 4.0 International license (CC BY 4.0) and may be reused according to the conditions of the license. For more details see: http://creativecommons.org/licenses/by/4.0/ A note on versions: The version presented in WRAP is the published version, or, version of record, and may be cited as it appears here. For more information, please contact the WRAP Team at: [email protected] warwick.ac.uk/lib-publications ORIGINAL RESEARCH published: 08 June 2018 doi: 10.3389/fnins.2018.00382 Biochemical, Anatomical, and Pharmacological Characterization of Calcitonin-Type Neuropeptides in Starfish: Discovery of an Ancient Role as Muscle Relaxants Weigang Cai 1, Chan-Hee Kim 2, Hye-Jin Go 2, Michaela Egertová 1, Cleidiane G. Zampronio 3, Alexandra M. Jones 3, Nam Gyu Park 2* and Maurice R. Elphick 1* 1 School of Biological & Chemical Sciences, Queen Mary University of London, London, United Kingdom, 2 Department of Biotechnology, College of Fisheries Sciences, Pukyong National University, Busan, South Korea, 3 School of Life Sciences and Proteomics Research Technology Platform, University of Warwick, Coventry, United Kingdom Calcitonin (CT) is a peptide hormone released by the thyroid gland that regulates blood Ca2+ levels in mammals.
    [Show full text]
  • G Protein-Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
    [Show full text]
  • Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors
    Journal of Nuclear Medicine, published on September 4, 2014 as doi:10.2967/jnumed.114.142000 CONTINUING EDUCATION Targeting Neuropeptide Receptors for Cancer Imaging and Therapy: Perspectives with Bombesin, Neurotensin, and Neuropeptide-Y Receptors Clément Morgat1–3, Anil Kumar Mishra2–4, Raunak Varshney4, Michèle Allard1,2,5, Philippe Fernandez1–3, and Elif Hindié1–3 1CHU de Bordeaux, Service de Médecine Nucléaire, Bordeaux, France; 2University of Bordeaux, INCIA, UMR 5287, Talence, France; 3CNRS, INCIA, UMR 5287, Talence, France; 4Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and Allied Sciences, DRDO, New Delhi, India; and 5EPHE, Bordeaux, France Learning Objectives: On successful completion of this activity, participants should be able to list and discuss (1) the presence of bombesin receptors, neurotensin receptors, or neuropeptide-Y receptors in some major tumors; (2) the perspectives offered by radiolabeled peptides targeting these receptors for imaging and therapy; and (3) the choice between agonists and antagonists for tumor targeting and the relevance of various PET radionuclides for molecular imaging. Financial Disclosure: The authors of this article have indicated no relevant relationships that could be perceived as a real or apparent conflict of interest. CME Credit: SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians. SNMMI designates each JNM continuing education article for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. For CE credit, SAM, and other credit types, participants can access this activity through the SNMMI website (http://www.snmmilearningcenter.org) through October 2017.
    [Show full text]
  • Evolution of Neuropeptide Signalling Systems (Doi:10.1242/Jeb.151092) Maurice R
    © 2018. Published by The Company of Biologists Ltd | Journal of Experimental Biology (2018) 221, jeb193342. doi:10.1242/jeb.193342 CORRECTION Correction: Evolution of neuropeptide signalling systems (doi:10.1242/jeb.151092) Maurice R. Elphick, Olivier Mirabeau and Dan Larhammar There was an error published in J. Exp. Biol. (2018) 221, jeb151092 (doi:10.1242/jeb.151092). In Fig. 2, panels B and C are identical. The correct figure is below. The authors apologise for any inconvenience this may have caused. Journal of Experimental Biology 1 © 2018. Published by The Company of Biologists Ltd | Journal of Experimental Biology (2018) 221, jeb151092. doi:10.1242/jeb.151092 REVIEW Evolution of neuropeptide signalling systems Maurice R. Elphick1,*,‡, Olivier Mirabeau2,* and Dan Larhammar3,* ABSTRACT molecular to the behavioural level (Burbach, 2011; Schoofs et al., Neuropeptides are a diverse class of neuronal signalling molecules 2017; Taghert and Nitabach, 2012; van den Pol, 2012). that regulate physiological processes and behaviour in animals. Among the first neuropeptides to be chemically identified in However, determining the relationships and evolutionary origins of mammals were the hypothalamic neuropeptides vasopressin and the heterogeneous assemblage of neuropeptides identified in a range oxytocin, which act systemically as hormones (e.g. regulating of phyla has presented a huge challenge for comparative physiologists. diuresis and lactation) and act within the brain to influence social Here, we review revolutionary insights into the evolution of behaviour (Donaldson and Young, 2008; Young et al., 2011). neuropeptide signalling that have been obtained recently through Evidence of the evolutionary antiquity of neuropeptide signalling comparative analysis of genome/transcriptome sequence data and by emerged with the molecular identification of neuropeptides in – ‘deorphanisation’ of neuropeptide receptors.
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]
  • Identification of Neuropeptide Receptors Expressed By
    RESEARCH ARTICLE Identification of Neuropeptide Receptors Expressed by Melanin-Concentrating Hormone Neurons Gregory S. Parks,1,2 Lien Wang,1 Zhiwei Wang,1 and Olivier Civelli1,2,3* 1Department of Pharmacology, University of California Irvine, Irvine, California 92697 2Department of Developmental and Cell Biology, University of California Irvine, Irvine, California 92697 3Department of Pharmaceutical Sciences, University of California Irvine, Irvine, California 92697 ABSTRACT the MCH system or demonstrated high expression lev- Melanin-concentrating hormone (MCH) is a 19-amino- els in the LH and ZI, were tested to determine whether acid cyclic neuropeptide that acts in rodents via the they are expressed by MCH neurons. Overall, 11 neuro- MCH receptor 1 (MCHR1) to regulate a wide variety of peptide receptors were found to exhibit significant physiological functions. MCH is produced by a distinct colocalization with MCH neurons: nociceptin/orphanin population of neurons located in the lateral hypothala- FQ opioid receptor (NOP), MCHR1, both orexin recep- mus (LH) and zona incerta (ZI), but MCHR1 mRNA is tors (ORX), somatostatin receptors 1 and 2 (SSTR1, widely expressed throughout the brain. The physiologi- SSTR2), kisspeptin recepotor (KissR1), neurotensin cal responses and behaviors regulated by the MCH sys- receptor 1 (NTSR1), neuropeptide S receptor (NPSR), tem have been investigated, but less is known about cholecystokinin receptor A (CCKAR), and the j-opioid how MCH neurons are regulated. The effects of most receptor (KOR). Among these receptors, six have never classical neurotransmitters on MCH neurons have been before been linked to the MCH system. Surprisingly, studied, but those of most neuropeptides are poorly several receptors thought to regulate MCH neurons dis- understood.
    [Show full text]
  • Download (750Kb)
    The potential role of the novel hypothalamic neuropeptides nesfatin-1, phoenixin, spexin and kisspeptin in the pathogenesis of anxiety and anorexia nervosa. Artur Pałasz a, Małgorzata Janas-Kozik b, Amanda Borrow c, Oscar Arias-Carrión d , John J. Worthington e a Department of Histology, School of Medicine in Katowice, Medical University of Silesia, ul. Medyków 18, 40-752, Katowice, Poland b Department of Psychiatry and Psychotherapy, School of Medicine in Katowice, Medical University of Silesia, ul. Ziolowa 45/47 Katowice, 40-635, Poland c Department of Biomedical Sciences, Colorado State University, Fort Collins, CO, 80523- 161, US d Unidad de Trastornos del Movimiento y Sueño, Hospital General Dr Manuel Gea Gonzalez, Mexico City, Mexico e Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, LA1 4YQ, UK Abstract Due to the dynamic development of molecular neurobiology and bioinformatic methods several novel brain neuropeptides have been identified and characterized in recent years. Contemporary techniques of selective molecular detection e.g. in situ Real-Time PCR, microdiffusion and some bioinformatics strategies that base on searching for single structural features common to diverse neuropeptides such as hidden Markov model (HMM) have been successfully introduced. A convincing majority of neuropeptides have unique properties as well as a broad spectrum of physiological activity in numerous neuronal pathways including the hypothalamus and limbic system. The newly discovered but uncharacterized regulatory factors nesfatin-1, phoenixin, spexin and kisspeptin have the potential to be unique modulators of stress responses and eating behaviour. Accumulating basic studies revelaed an intriguing role of these neuropeptides in the brain pathways involved in the pathogenesis of anxiety behaviour.
    [Show full text]
  • Rfamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
    Pharmaceuticals 2011, 4, 1248-1280; doi:10.3390/ph4091248 OPEN ACCESS Pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Review RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential Maria Findeisen †, Daniel Rathmann † and Annette G. Beck-Sickinger * Institute of Biochemistry, Leipzig University, Brüderstraße 34, 04103 Leipzig, Germany; E-Mails: [email protected] (M.F.); [email protected] (D.R.) † These authors contributed equally to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +49-341-9736900; Fax: +49-341-9736909. Received: 29 August 2011; in revised form: 9 September 2011 / Accepted: 15 September 2011 / Published: 21 September 2011 Abstract: Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family.
    [Show full text]
  • New Insights Into Metabolic Homeostasis Keith Tan
    Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2015 Activity Based Profiling: New Insights into Metabolic Homeostasis Keith Tan Follow this and additional works at: http://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons Recommended Citation Tan, Keith, "Activity Based Profiling: New Insights into Metabolic Homeostasis" (2015). Student Theses and Dissertations. Paper 285. This Thesis is brought to you for free and open access by Digital Commons @ RU. It has been accepted for inclusion in Student Theses and Dissertations by an authorized administrator of Digital Commons @ RU. For more information, please contact [email protected]. ACTIVITY BASED PROFILING: NEW INSIGHTS INTO METABOLIC HOMEOSTASIS A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Keith Tan June 2015 © Copyright by Keith Tan 2015 ACTIVITY BASED PROFILING: NEW INSIGHTS INTO METABOLIC HOMEOSTASIS Keith Tan, Ph.D. The Rockefeller University 2015 There is mounting evidence that demonstrates that body weight and energy homeostasis is tightly regulated by a physiological system. This system consists of sensing and effector components that primarily reside in the central nervous system and disruption to these components can lead to obesity and metabolic disorders. Although many neural substrates have been identified in the past decades, there is reason to believe that there are numerous unidentified neural populations that play a role in energy balance. Besides regulating caloric consumption and energy expenditure, neural components that control energy homeostasis are also tightly intertwined with circadian rhythmicity but this aspect has received less attention.
    [Show full text]
  • Existence and Functions of a Kisspeptin Neuropeptide Signaling
    RESEARCH ARTICLE Existence and functions of a kisspeptin neuropeptide signaling system in a non- chordate deuterostome species Tianming Wang1,2†*, Zheng Cao3†, Zhangfei Shen3†, Jingwen Yang1,2, Xu Chen1, Zhen Yang1, Ke Xu1, Xiaowei Xiang1, Qiuhan Yu1, Yimin Song1, Weiwei Wang3, Yanan Tian3, Lina Sun4, Libin Zhang4,5, Su Guo2, Naiming Zhou3* 1National Engineering Research Center of Marine Facilities Aquaculture, Marine Science College, Zhejiang Ocean University, Zhoushan, China; 2Programs in Human Genetics and Biological Sciences, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, United States; 3Institute of Biochemistry, College of Life Sciences, Zijingang Campus, Zhejiang University, Hangzhou, China; 4Key Laboratory of Marine Ecology and Environmental Sciences, Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China; 5Center for Ocean Mega-Science, Chinese Academy of Sciences, Qingdao, China Abstract The kisspeptin system is a central modulator of the hypothalamic-pituitary-gonadal axis in vertebrates. Its existence outside the vertebrate lineage remains largely unknown. Here, we report the identification and characterization of the kisspeptin system in the sea cucumber Apostichopus japonicus. The gene encoding the kisspeptin precursor generates two mature neuropeptides, AjKiss1a and AjKiss1b. The receptors for these neuropeptides, AjKissR1 and AjKissR2, are strongly activated by synthetic A. japonicus and vertebrate kisspeptins, triggering a *For correspondence: rapid intracellular mobilization of Ca2+, followed by receptor internalization. AjKissR1 and AjKissR2 [email protected] (TW); share similar intracellular signaling pathways via G /PLC/PKC/MAPK cascade, when activated by [email protected] (NZ) aq C-terminal decapeptide. The A. japonicus kisspeptin system functions in multiple tissues that are † These authors contributed closely related to seasonal reproduction and metabolism.
    [Show full text]